FOGHORN THERAPEUTICS INC (FHTX)

US3441741077 - Common Stock

5.99  -0.12 (-1.96%)

After market: 5.99 0 (0%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
34.16M19.23M1.32M430.00K0.00
Operating Expenses
142.06M136.37M102.06M68.96M51.08M
Research and Development
109.69M105.62M80.33M57.72M44.36M
Selling, General, and Administrative Expenses
32.37M30.75M21.73M11.25M6.72M
Operating Income
-107.91M-117.14M-100.74M-68.53M-51.08M
Interest Income/Expense
10.88M5.68M-1.91M-980.00K-540.00K
Other Income/Expense
2.83M2.58M2.55M930.00K500.00K
Non Recurring Items
N/A0.00-1.23M-220.00KN/A
Income Before Taxes
-94.20M-108.88M-101.32M-68.80M-51.13M
Income Tax
4.23MN/AN/AN/AN/A
Net Income
-98.43M-108.88M-101.32M-68.80M-51.13M
EBITDA
-104.45M-113.84M-97.54M-67.23M-50.38M
 
Per Share Data
EPS Diluted Total Ops
-2.34-2.62-2.73-1.87-4.70
Non GAAP EPS
-2.34-2.62-2.70N/AN/A
 
Statistics
Profit Margin
-288.17%-566.20%-7675.76%-16000.00%N/A
Operating Profit Margin
-315.93%-609.15%-7631.82%-15937.21%N/A

All data in USD

Charts